Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.17M Sell
20,683
-139
-0.7% -$7.75K 0.05% 191
2026
Q1
$1.19M Sell
20,822
-250
-1% -$14.2K 0.05% 178
2025
Q4
$1.12M Sell
21,072
-235
-1% -$12.3K 0.05% 180
2025
Q3
$1.06M Sell
21,307
-903
-4% -$45.8K 0.05% 176
2025
Q2
$1.14M Buy
22,210
+92
+0.4% +$4.68K 0.06% 167
2025
Q1
$1.18M Buy
22,118
+88
+0.4% +$4.61K 0.06% 162
2024
Q4
$1.05M Buy
22,030
+99
+0.5% +$4.61K 0.05% 173
2024
Q3
$975K Buy
21,931
+96
+0.4% +$4.1K 0.05% 175
2024
Q2
$930K Buy
+21,835
New +$899K 0.05% 173

Other funds holding MPLX

Trilogy Capital's MPLX Position: Q2 2026 in Review

Trilogy Capital reduced its MPLX (MPLX) stake by 0.67% in Q2 2026, selling an estimated $7.75K and leaving 20,683 shares worth $1.17M. The position accounts for 0.05% of the portfolio, ranked #191.

Trilogy Capital first reported a position in MPLX in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.19M in Q1 2026. 101 funds tracked by Wall St. Rank hold MPLX as of Q2 2026.

  • Trilogy Capital held 20,683 shares of MPLX worth $1.17M as of Q2 2026.
  • Trilogy Capital sold 139 MPLX shares in Q2 2026, an estimated $7.75K.
  • MPLX made up 0.05% of Trilogy Capital's portfolio in Q2 2026, its #191 holding.
  • Trilogy Capital first reported a position in MPLX in Q2 2024 and has held it in 9 quarters since.
  • Trilogy Capital's MPLX position peaked at $1.19M in Q1 2026.
  • 101 funds tracked by Wall St. Rank held MPLX as of Q2 2026.

Based on Trilogy Capital's 13F filing for Q2 2026, filed 6 Jul 2026.